Literature DB >> 1941861

Antiphospholipid syndrome and acute adrenal insufficiency.

A Dorling1, G K Knowles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1941861      PMCID： PMC1293423          DOI： 10.1177/014107689108400920

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  8 in total

Review 1.  Bilateral massive adrenal hemorrhage: early recognition and treatment.

Authors:  R H Rao; A H Vagnucci; J A Amico
Journal:  Ann Intern Med       Date:  1989-02-01       Impact factor: 25.391

2.  Addison's disease and primary antiphospholipid syndrome.

Authors:  R A Asherson; G R Hughes
Journal:  Lancet       Date:  1989-10-07       Impact factor: 79.321

3.  Lupus anticoagulant.

Authors:  A S Yap; E E Powell; C E Yelland; R H Mortimer; D A Perry-Keene
Journal:  Ann Intern Med       Date:  1989-08-01       Impact factor: 25.391

4.  Acute adrenal insufficiency as a manifestation of the anticardiolipin syndrome?

Authors:  S Carette; F Jobin
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

Review 5.  Anticardiolipin antibodies--clinical associations.

Authors:  R A Asherson; E N Harris
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

6.  The "primary" antiphospholipid syndrome: major clinical and serological features.

Authors:  R A Asherson; M A Khamashta; J Ordi-Ros; R H Derksen; S J Machin; J Barquinero; H H Outt; E N Harris; M Vilardell-Torres; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1989-11       Impact factor: 1.889

7.  Venous thrombosis associated with lupus anticoagulant and anticardiolipin antibodies.

Authors:  P Pelkonen; O Simell; V Rasi; O Vaarala
Journal:  Acta Paediatr Scand       Date:  1988-09

8.  Recurrent deep vein thrombosis and Addison's disease in "primary" antiphospholipid syndrome.

Authors:  R A Asherson; G R Hughes
Journal:  J Rheumatol       Date:  1989-03       Impact factor: 4.666
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.